3 ms·
We think it just reduces some of the brain inflammation and thus alleviates some of the symptoms. Its also a treatment sufferers become tolerant to and it stops
by PaulKeeble 3y ago
We think it just reduces some of the brain inflammation and thus alleviates some of the symptoms. Its also a treatment sufferers become tolerant to and it stops working. Its also very hard to dose right and requires constant adjustments and its not without side effects that often make it not worthwhile and for some people it never works.
It should be authorised as a treatment for ME/CFS and Long Covid in the short term alongside Ablify as sufferers should get to try these and see if they work but they are both very far from a good treatment and do nothing for the core parts of the condition.
- nradov 3y agoThere's no process to "authorize" an existing approved prescription drug as a treatment for ME/CFS and Long COVID. Doctors can already prescribe those drugs off label if they wish (although the patient might have trouble getting insurance coverage for those claims depending on their policy). In order to make them on-label treatments then the drug company or some other party will have to conduct a large-scale clinical trial and go through the FDA regulatory process to prove that it is safe and effective. This is expensive, but drug companies do such studies all the time in order to increase revenue and extend patent protections.
- GordonS 3y agoIt depends on the country. In the UK for example, medications are indeed licensed to treat certain conditions. Specialist doctors are able to prescribe off-label regardless, but most are reticent to do so.